Medicenna Therapeutics annual shares outstanding
2019
2020
2021
2022
2023
Medicenna Therapeutics Shares Outstanding History (MDNAF)
Medicenna Therapeutics reported 69.6M shares outstanding at the end of fiscal 2023.
View full Medicenna Therapeutics company overviewMedicenna Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-03-31 | 69.6M | 14.0M | +25.14% |
| 2022 | 2022-03-31 | 55.6M | 2.1M | +3.92% |
| 2021 | 2021-03-31 | 53.5M | 6.7M | +14.42% |
| 2020 | 2020-03-31 | 46.8M | 18.2M | +63.76% |
| 2019 | 2019-03-31 | 28.6M | — | — |
Medicenna Therapeutics quarterly shares outstanding
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-03-31 | 69.6M | 41.1M | +143.67% |
| Q4 2022 | 2022-03-31 | 55.6M | — | — |
| Q4 2021 | 2021-03-31 | 53.5M | — | — |
| Q4 2020 | 2020-03-31 | 46.8M | — | — |
| Q4 2019 | 2019-03-31 | 28.6M | — | — |
Medicenna Therapeutics shares outstanding trends
Across the available reported history, Medicenna Therapeutics's shares outstanding moved from 55.6M to 69.6M, a change of 14.0M. The latest reported quarter, Q4 2023, shows 69.6M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicenna Therapeutics filings at SEC.gov ↗